Codon deoptimization technology

Source: TH  Context: Indian Immunologicals Ltd (IIL), in collaboration with Griffith University, Australia, has developed a needle-free intranasal COVID-19 booster vaccine using codon deoptimization technology. This live-attenuated vaccine, which modulates viral attenuation by adjusting genetic codons, is designed to be safe and quick to produce.